Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth
about
Glycomic Approaches for the Discovery of Targets in Gastrointestinal CancerUse of lectin microarray to differentiate gastric cancer from gastric ulcer.Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients.Overexpression of Galnt3 in chondrocytes resulted in dwarfism due to the increase of mucin-type O-glycans and reduction of glycosaminoglycansAntitumor activity of (R,R')-4-methoxy-1-naphthylfenoterol in a rat C6 glioma xenograft model in the mouseNovel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk.Synthesis and cell-selective antitumor properties of amino acid conjugated tumor-associated carbohydrate antigen-coated gold nanoparticles.MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7.Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification.Functional elucidation of miR-494 in the tumorigenesis of nasopharyngeal carcinoma.A systematic study of modulation of ADAM-mediated ectodomain shedding by site-specific O-glycosylation.Deconstruction of O-glycosylation--GalNAc-T isoforms direct distinct subsets of the O-glycoproteome.MicroRNA Profiling in Patients with Upper Tract Urothelial Carcinoma Associated with Balkan Endemic NephropathyThe lectin domain of the polypeptide GalNAc transferase family of glycosyltransferases (ppGalNAc Ts) acts as a switch directing glycopeptide substrate glycosylation in an N- or C-terminal direction, further controlling mucin type O-glycosylationTrimeric Tn antigen on syndecan 1 produced by ppGalNAc-T13 enhances cancer metastasis via a complex formation with integrin α5β1 and matrix metalloproteinase 9.Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation.Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.The Cosmc connection to the Tn antigen in cancer.Precision genome editing: a small revolution for glycobiology.Loss of N-Acetylgalactosaminyltransferase-4 Orchestrates Oncogenic MicroRNA-9 in Hepatocellular Carcinoma.GALNT7, a target of miR-494, participates in the oncogenesis of nasopharyngeal carcinoma.COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.Polypeptide N-acetylgalactosaminyltransferase-6 expression in gastric cancer.shRNA-mediated downregulation of α-N-Acetylgalactosaminidase inhibits migration and invasion of cancer cell lines.Increased expression of GCNT1 is associated with altered O-glycosylation of PSA, PAP, and MUC1 in human prostate cancers.Elevated Expression of N-Acetylgalactosaminyltransferase 10 Predicts Poor Survival and Early Recurrence of Patients with Clear-Cell Renal Cell Carcinoma.De novo expression of human polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epithelium.miR-214 inhibits invasion and migration via downregulating GALNT7 in esophageal squamous cell cancer.Polypeptide-GalNAc-T6 expression predicts better overall survival in patients with colon cancer.LncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1.Knockdown of FUT3 disrupts the proliferation, migration, tumorigenesis and TGF-β induced EMT in pancreatic cancer cells.Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression.
P2860
Q26750872-AECE4D80-A41D-4C60-8AF0-28AC7F36F2D5Q33594943-CFD970A8-F7F6-4F35-A8AD-5872147B32E2Q34058682-998EFAE7-198C-4111-87AB-791912402750Q34249099-B69F457E-3830-498F-90E7-D7E1611C3861Q34292538-0A4736AD-BCF2-4C4F-9DFC-CDB827313F6DQ35160562-B711E52F-8705-467D-86C7-8BC8FDEF7639Q35162645-51244C95-1EAE-4977-9E0A-D1D603E1BC5CQ35922278-B2218CA8-012C-4737-91B7-EC469C576765Q36239980-6B745D56-5185-4D12-A6AE-33C0C24D867EQ36278144-C51AABB0-D827-4A50-B751-AA267DEA5338Q36332111-78B70697-485D-40FC-89CE-D06DAAED2255Q36410184-DCAA6171-5FF2-4C37-89D8-7AB1A6A7ADA1Q36889708-C29747EE-10B3-4D7A-9D27-AEF5DE9D7053Q37000627-659475AC-B283-4CDB-A427-F5F4AD09FA7FQ37099808-FEF271D2-2462-4034-B24B-1BA3D344B881Q37174016-308B15A7-5C7C-46B4-8DCE-F8298C47587BQ37660331-1C5259BA-B460-46A9-BE10-576668AA19E2Q38197051-6F5FD638-8158-4D68-A64D-27E681649090Q38214809-92E7E5C8-B431-4F64-B9D6-53222DF91BB6Q38722581-E766907A-C7E9-475E-8B7C-D7419DDEB688Q38824800-09D59F48-EFFF-4076-A4F2-69D82F924FE3Q38869978-0065CA24-C1D2-4755-A5B9-806279C741A6Q40108489-13E336C1-3DAD-4A03-95D1-BCD6A5CA42BDQ45873773-AE11F63D-9B1F-420F-A39D-E4B360B11335Q46091778-3558B8F1-E77B-4901-9089-9F3F847A8437Q46773554-A416CC0A-5B66-4549-AA26-43A8016FD92CQ47301558-4F597DEE-F9F6-4B24-BAC6-C3DE9BB4E4C8Q51813879-E90076EB-6A4E-4C7F-AFC9-C080BFF1FCCBQ55284634-B57B6050-551E-4277-838E-E78B5C7F9EF7Q55348071-92A3989F-34B9-4974-A8D7-FD28D588106BQ55361796-E7DE80A4-BEA5-476E-B439-ACEB28719DEBQ55517874-A49AEB15-EB75-4512-8576-12F001E3A819
P2860
Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth
@ast
Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth
@en
type
label
Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth
@ast
Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth
@en
prefLabel
Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth
@ast
Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth
@en
P2093
P2860
P356
P1433
P1476
Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth
@en
P2093
A Tanouchi
K Taniuchi
M A Hollingsworth
P2860
P2888
P304
P356
10.1038/ONC.2011.194
P407
P577
2011-05-30T00:00:00Z